Expression of HER-2 and TOPO- Ⅱα in ovarian epithelial cancer and its clinical significance
10.3760/cma.j.issn.1008-6315.2011.03.029
- VernacularTitle:人类表皮生长因子受体-2和拓扑异构酶Ⅱ在卵巢上皮癌中的表达及其临床意义
- Author:
Sushuang SHANG
;
Jing ZHANG
;
Jia CHENG
;
Yuehuan REN
;
Liling ZHANG
;
Lixia PAN
;
Xiang GAO
;
Hua YU
- Publication Type:Journal Article
- Keywords:
Epithelial ovarian carcinoma;
HER-2;
TOPO- Ⅱα;
immunohistochemistry
- From:
Clinical Medicine of China
2011;27(3):302-305
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the expression of HER-2 and TOPO-Ⅱα in ovarian epithelial cancer,analyze the correlation between their expression and provide theoretical basis for clinical diagnosis,prognosis and treatment. Methods Expression levels of HER-2 and TOPO- Ⅱα in 10 normal ovarian tissues,20 benign tumors and 58 cases of ovarian epithelial cancers were detected by immunohistochemical method, and their correlations with pathological features were analyzed. Results The positive expression rate of HER-2 in normal ovarian and benign tumor tissues were significantly lower than ovarian epithelial cancers respectively ( 10. 0% , 15.0% VS 46. 6% ;P ＜ 0. 05 ). The positive expression rate of TOPO- Ⅱα in ovarian epithelial cancers was significantly higher than normal and benign epithelial ovarian tumor tissue (53.4% vs 10. 0%, and 15.0%,Ps ＜ 0. 05 ), but we did not find significant difference in the comparison between normal and benign epithelial ovarian tumor tissue ( Ps ＞ 0. 05 ). The expression of HER-2 and TOPO- Ⅱα were significantly correlated with clinical stages, histological differentiation of tumor cells (Ps ＜ 0. 05 ) ,but there were no correlations between the age or histological type. In ovarian cancer tissues, a positive correlation between the expression of HER-2 and TOPO- Ⅱα was observed ( r = 0. 324, P ＜ 0. 05 ) . Conclusion The overexpression of HER-2 and TOPO- Ⅱαplay an important role in ovarian carcinogenesis and development. The expression of HER-2 is positively correlated with TOPO- Ⅱα in ovarian epithelial cancers. Coexpression of the two moleculars may be involved in the development and progression of ovarian epithelial cancer, which should be further studied.
